11-3825023-C-T

Variant summary

Our verdict is Likely benign. The variant received -3 ACMG points: 2P and 5B. PM5BP4_StrongBS1_Supporting

The NM_014489.4(PGAP2):​c.712C>T​(p.Arg238Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00073 in 1,614,126 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R238P) has been classified as Likely pathogenic.

Frequency

Genomes: 𝑓 0.00050 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00075 ( 1 hom. )

Consequence

PGAP2
NM_014489.4 missense

Scores

3
15

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:3

Conservation

PhyloP100: 1.75

Publications

6 publications found
Variant links:
Genes affected
PGAP2 (HGNC:17893): (post-GPI attachment to proteins 2) The protein encoded by this gene plays a role in the maturation of glycosylphosphatidylinositol (GPI) anchors on GPI-anchored proteins. Mutations in this gene are associated with an autosomal recessive syndrome characterized by hyperphosphatasia and intellectual disability. [provided by RefSeq, Jul 2017]
PGAP2 Gene-Disease associations (from GenCC):
  • hyperphosphatasia with intellectual disability syndrome 3
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • hyperphosphatasia-intellectual disability syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -3 ACMG points.

PM5
Other missense variant is known to change same aminoacid residue: Variant chr11-3825024-G-C is described in ClinVar as Pathogenic/Likely_pathogenic. ClinVar VariationId is 50503.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP4
Computational evidence support a benign effect (MetaRNN=0.0274072).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000499 (76/152292) while in subpopulation NFE AF = 0.000823 (56/68032). AF 95% confidence interval is 0.000651. There are 0 homozygotes in GnomAd4. There are 38 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_014489.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PGAP2
NM_014489.4
MANE Select
c.712C>Tp.Arg238Cys
missense
Exon 6 of 7NP_055304.1
PGAP2
NM_001256236.2
c.712C>Tp.Arg238Cys
missense
Exon 7 of 8NP_001243165.2
PGAP2
NM_001346397.2
c.682C>Tp.Arg228Cys
missense
Exon 6 of 7NP_001333326.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PGAP2
ENST00000278243.9
TSL:1 MANE Select
c.712C>Tp.Arg238Cys
missense
Exon 6 of 7ENSP00000278243.4
PGAP2
ENST00000300730.10
TSL:1
c.688C>Tp.Arg230Cys
missense
Exon 6 of 7ENSP00000300730.6
PGAP2
ENST00000396993.8
TSL:1
c.61C>Tp.Arg21Cys
missense
Exon 5 of 6ENSP00000380190.6

Frequencies

GnomAD3 genomes
AF:
0.000499
AC:
76
AN:
152174
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000362
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000769
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000823
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000422
AC:
106
AN:
251420
AF XY:
0.000346
show subpopulations
Gnomad AFR exome
AF:
0.000185
Gnomad AMR exome
AF:
0.0000289
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000381
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000826
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000755
AC:
1103
AN:
1461834
Hom.:
1
Cov.:
32
AF XY:
0.000715
AC XY:
520
AN XY:
727224
show subpopulations
African (AFR)
AF:
0.000209
AC:
7
AN:
33480
American (AMR)
AF:
0.0000224
AC:
1
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26134
East Asian (EAS)
AF:
0.000176
AC:
7
AN:
39700
South Asian (SAS)
AF:
0.0000232
AC:
2
AN:
86252
European-Finnish (FIN)
AF:
0.0000374
AC:
2
AN:
53420
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.000949
AC:
1055
AN:
1111968
Other (OTH)
AF:
0.000480
AC:
29
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
64
129
193
258
322
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000499
AC:
76
AN:
152292
Hom.:
0
Cov.:
32
AF XY:
0.000510
AC XY:
38
AN XY:
74458
show subpopulations
African (AFR)
AF:
0.000361
AC:
15
AN:
41554
American (AMR)
AF:
0.00
AC:
0
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.000771
AC:
4
AN:
5188
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000823
AC:
56
AN:
68032
Other (OTH)
AF:
0.000473
AC:
1
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
4
8
12
16
20
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000607
Hom.:
0
Bravo
AF:
0.000453
TwinsUK
AF:
0.00135
AC:
5
ALSPAC
AF:
0.00130
AC:
5
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00116
AC:
10
ExAC
AF:
0.000445
AC:
54
EpiCase
AF:
0.000654
EpiControl
AF:
0.000533

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:2
Dec 21, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 177 of the PGAP2 protein (p.Arg177Cys). This variant is present in population databases (rs117338939, gnomAD 0.08%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with PGAP2-related conditions. ClinVar contains an entry for this variant (Variation ID: 377014). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PGAP2 protein function with a positive predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

Dec 05, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Inborn genetic diseases Uncertain:1
Aug 06, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.712C>T (p.R238C) alteration is located in exon 6 (coding exon 5) of the PGAP2 gene. This alteration results from a C to T substitution at nucleotide position 712, causing the arginine (R) at amino acid position 238 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.29
T
BayesDel_noAF
Benign
-0.22
CADD
Pathogenic
27
DANN
Benign
0.94
DEOGEN2
Uncertain
0.72
D
Eigen
Benign
0.034
Eigen_PC
Benign
0.11
FATHMM_MKL
Benign
0.044
N
LIST_S2
Benign
0.85
D
M_CAP
Benign
0.012
T
MetaRNN
Benign
0.027
T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
1.5
L
PhyloP100
1.7
PrimateAI
Benign
0.38
T
PROVEAN
Uncertain
-2.7
D
REVEL
Benign
0.14
Sift
Uncertain
0.0080
D
Sift4G
Benign
0.088
T
Polyphen
0.049
B
Vest4
0.38
MVP
0.43
MPC
0.52
ClinPred
0.047
T
GERP RS
5.3
Varity_R
0.13
gMVP
0.55
Mutation Taster
=61/39
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs117338939; hg19: chr11-3846253; COSMIC: COSV53467717; COSMIC: COSV53467717; API